The PE Ratio as of December 2025 (TTM) for Kairos Pharma, Ltd. (KAPA) is -2.93

According to Kairos Pharma, Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -2.93. This represents a change of -19.96% compared to the average of -3.66 of the last 4 quarters.

Kairos Pharma, Ltd. (KAPA) Historical PE Ratio (quarterly & annually)

How has KAPA PE Ratio performed in the past?

The mean historical PE Ratio of Kairos Pharma, Ltd. over the last ten years is -18.04. The current -2.93 PE Ratio has changed 1.52% with respect to the historical average. Over the past ten years (40 quarters), KAPA's PE Ratio was at its highest in in the June 2025 quarter at -2.15. The PE Ratio was at its lowest in in the March 2023 quarter at -46.01.

Kairos Pharma, Ltd. (KAPA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kairos Pharma, Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kairos Pharma, Ltd. (KAPA) Average PE Ratio

How has KAPA PE Ratio performed in the past?

The current PE Ratio of Kairos Pharma, Ltd. (KAPA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kairos Pharma, Ltd. (KAPA) PE Ratio vs. Peers

How is KAPA’s PE Ratio compared to its peers?

Kairos Pharma, Ltd.’s PE Ratio is greater than Lixte Biotechnology Holdings, Inc. (-3.74), greater than Pelthos Therapeutics Inc. (-3.42), less than Lexaria Bioscience Corp. (-1.80), less than CASI Pharmaceuticals, Inc. (-0.32), less than Allarity Therapeutics, Inc. (-1.12), less than Clearside Biomedical, Inc. (-0.18), less than Cingulate Inc. (-0.00), less than BriaCell Therapeutics Corp. (-2.37), less than Entero Therapeutics, Inc. (-0.25), less than Pulmatrix, Inc. (-2.51),

Build a custom stock screener for Kairos Pharma, Ltd. (KAPA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kairos Pharma, Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kairos Pharma, Ltd. (KAPA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kairos Pharma, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.